"There is a very real chance NWBO never submits a BLA for DCVax-L.
They have never, not once, said anything about plans to submit to the FDA."
I also do not recall that NWBO mentioned its intention to submit applications to
the EU. If that fact can be taken as evidence, we should also assume that any
potential treatments developed from the combo trials at UCLA, Roswell
Park, the DCVax-D trials and any future partnership trials, will be limited to
the UK market. What a waste that would be.
I don't believe that to be very realistic and instead believe that NWBO will tell
us something about the goals of future combo trials (e.g. tumor shrinkage)
but not about the identity of intended partnerships or intended targets for their next
application for approval. The only exception to that was that they did not hide their
intent to submit their first application for approval to the MHRA.
Bullish
Market Data 
Markets 
AI
